Effects of Angipars on oxidative inflammatory indices in a murine model of periodontitis by Mousavi-Jazi, M. et al.
260
Effects of Angipars on oxidative inflammatory indices in a murine model 
of periodontitis 
1Mousavi-Jazi M., 1Aslroosta H., 2Moayer A.R., 3Baeeri M., *3Abdollahi M.
1Department of Periodontology, School of Dentistry and Dental Research Center, Tehran 
University of Medical Sciences, 2Department of Periodontology, School of Dentistry, Islamic 
Azad University, 3Faculty of Pharmacy, and Pharmaceutical Science Research Center, Tehran 
University of Medical Sciences, Tehran, Iran.
Received 23 May 2010; Revised 19 Oct 2010; Accepted 25 Oct 2010
ABSTRACT
Background and the purpose of the study: There are strong evidences linking overproduction of 
reactive oxygen species and periodontal diseases. The aim of this study was to evaluate efficacy 
of Angipars a natural potent anti oxidative agent on markers of the oxidative damages and 
periodontal inflammation in the rat.
Methods:  Periodontitis  was  induced  by  single  injection  of  lipopolysaccharide (LPS)  from                           
E. coli (10 µg/µl saline) into rat mandibular gingiva. After 10 days, animals in the test group 
received Angipars (2.1 mg/kg) by gavage once a day and those of control group received 
same amount of vehicle. The amount of interleukin (IL)-1β, lipid peroxidation (LPO), and 
8-hydroxydeoxyguanosine (8-OHdG) were measured in gingival biopsy samples and the degree 
of apical migration of junctional epithelium (JE), alveolar bone resorption, and the number of 
polymorphonuclears (PMN) were evaluated by histological analysis of block samples of the left 
mandibular first molars.
Results: Periodontitis group showed a significant increase in periodontal IL-1β, LPO, 8-OHdG, 
apical migration of JE, alveolar bone resorption and number of PMNs. Angipars treatment 
resulted in a significant decrease in gingival IL-1β, LPO, 8-OHdG and the apical migration 
of JE; however, the reduction of alveolar bone resorption was not significant. The number of 
PMN increased significantly after treatment with Angipars. While intake of vehicle resulted in 
a significant decrease in gingival IL-1β and LPO, the reduction of 8-OHdG, apical migration 
of JE, and alveolar bone resorption were not significant. Interestingly, PMNs were increased in 
groups received Angipars or the vehicle. 
Conclusion: From the results of this study, it seems that Angipars is beneficial in periodontitis 
by reduction of inflammatory and oxidative damage. Unexpected increase of PMN count by 
Angipars strengthens the hypothesis that chronic inflammatory disorders like periodontitis may 
need more time to get best advantage of anti oxidative drugs like Angipars. Regarding role of 
microbes in pathogenesis of periodontitis, further studies should be focused on antimicrobial 
effects of Angipars. 
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INTRODUTION
Periodontal  diseases  including  gingivitis  and 
periodontitis  are  the  most  common  chronic 
inflammatory  diseases  among  populations  all 
over the world (1). The most important etiological 
factor  for  periodontal  diseases  is  bacteria  like 
Porphyromonas  gingivalis,  Actinobacillus 
actinomycetem commitans, and Tanerella forsythia 
(2).  In  patients  with  chronic  periodontitis,  an 
increase in oxidant products in serum, saliva and 
gingival crevicular fluid (GCF) (3) and a decrease in 
antioxidant capacity of GCF (4) have been reported. 
Also,  inflammatory  cytokines  such  as  interleukin 
(IL)-1β (5), IL-6 (6), cyclic nucleotides (7), and nitric 
oxide (NO) (8)  increased in periodontitis caused 
pathologically or upon adverse drug reactions (9). 
Angipars (Semelil)  is  a  registered  drug  derived 
from  a  plant  named  Melilotus  officinalis  under 
electromagnetic  processes  which  contains 
compounds  such  as  7-hydroxycoumarin  and 
flavonoidsused  and  is  available  as  a  suspension 
in  9.2%  ethanol. Angipars  has  passed  safety  and 
clinical trials processes and has been registered as 
a drug of choice for management of human diabetic 
foot (10-13). Coumarin which is the main component 
of  this  drug  is  known  for  its  anti-inflammatory 261
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Statistical analyses 
All values in the figures and text are presented as 
mean ± SE. Data were first examined for normality 
by  the  Kolmogorov-Smirnov  test  and  if  data  did 
not  achieve  normality,  analysis  was  performed 
using non-parametric methods. The values of apical 
migration of junctional epithelium and PMN count 
did  not  achieve  normality.  Univariate  analysis  of 
variance,  followed  by  Tukey`s  test  were  used  to 
compare the values of 8-OHdG, LPO and alveolar 
bone resorption. Levene test was used to compare 
IL-1β values. The difference in values of attachment 
level and PMN count between groups was analyzed 
using the Kruskal-Wallis test. 
RESULTS AND DISCUSSION
Animals  of  the  periodontitis  group  showed  a 
significant increase in gingival IL-1β, DNA damage 
and  LPO  levels  as  compared  with  normal  group. 
Meanwhile,  Angipars  significantly  reduced  LPS 
induced elevation of gingival IL-1β, DNA damage, 
and LPO. Interestingly, gingival IL-1β and LPO in 
the vehicle group was significantly reduced when 
compared with periodontitis group. Of course, DNA 
damages in vehicle group was not different from 
periodontitis group but was significantly higher than 
that of normal group. Consistent with this finding, it 
has been reported that gingival LPO in periodontitis 
is elevated through production of superoxide anion 
during interaction between bacterial LPS and PMNs 
within  periodontal  tissues (16).  Angipars  most 
probably has reduced gingival LPO and DNA damage 
because  of  its  main  component  called  coumarin. 
Coumarin has been found to reduce synthesis of NO 
in  the  phagocytes  as  an  anti-inflammatory  action 
(14). On the other hand, since Angipars is suspended 
in ethanol, thus anti-inflammatory effect of ethanol 
seems acting in synergism to reduce IL-1β and LPO 
(17). 
The  results  also  indicated  that  degree  of  apical 
migration of JE[the distance between the CEJ and the 
most coronal portion of JE], the degree of alveolar bone 
resorption (the distance between the cementoenamel 
junction (CEJ)  and  the  alveolar  bone  crest),  and 
PMNs  increased  in  periodontitis  group. Angipars 
caused a significant reduction in apical migration of 
JE, whereas the amount of alveolar bone resorption 
decreased  insignificantly (p  >  0.05). The  number 
of PMNs increased significantly in Angipars and 
vehicle groups compared with periodontitis group. 
There  was  no  significant  difference  in  the  apical 
migration of JE and alveolar bone resorption between 
vehicle  and  periodontitis  group.  Histological 
parameters  of  Angipars  group  compared  with 
normal  group  where  not  significantly  different 
except that there was a significant increase in PMN. 
The alveolar bone resorption in Angipars group was 
not  significantly  lower  than  that  of  periodontitis 
group, suggesting that Angipars does not affect the 
and  antioxidant  activity,  and  ability  to  suppress 
superoxide  and  NO  production  in  leukocytes, 
thereby, to reduce phagocyte activity (14).
The aim of this study was to evaluate the efficacy 
of  Angipars  on  experimental  periodontitis  by 
measurement of periodontal oxidative inflammatory 
and histological parameters. 
MATERIAL AND  METHODS
Thirty six male Wistar rats (12 weeks of age) were 
housed in an air conditioned room (23-25ºC) with a 
12 hrs dark and 12 hrs light cycle. The experimental 
protocol was approved by the institute review board. 
All  chemicals  were  obtained  from  Sigma-Aldrich 
Chemie (GmbhMunich, Germany) unless otherwise 
stated. LPO and IL-1β ELISA kits were purchased 
from Bendermed system (Austria) and DNA damage 
ELISA  kit  was  purchased  from  Cayman (USA). 
Angipars  was  obtained  from  Parsrus  Research 
Group (Tehran, Iran).
Induction  of  experimental  periodontitis  and 
treatments
The rats were divided into four groups (9 in each 
group).  One  group  received  no  treatment  for  the 
whole  study  and  was  assigned  as  normal  group. 
Periodontitis was induced in three test groups by 
injection of 10 µg of lipopolysaccharide (LPS) from 
E. coli in 1 µl saline into rat mandibular gingiva 
at  the  distiobaccal  aspect  of  the  first  molar (15). 
After  10  days (the  time  required  for  initiation  of 
periodontitis),  one  of  these  groups (periodontitis 
group), was sacrificed under general anesthesia by 
overdose  of  ketamine.  One  of  the  remaining  two 
groups (Angipars group) was treated with Angipars 
(2.1 mg/kg) by gavage once a day for 2 weeks. The 
other group assigned as vehicle group and received 
ethanol  9.2%.  After  2  weeks,  the  animals  were 
sacrificed by overdose of ketamine and then the left 
mandibular site was resected from each rat and fixed 
in formaldehyde (10%) in phosphate buffer (pH of 
7.4; 0.1 mol/l) for 1 day. Gingival biopsy samples of 
the right mandibulare first molar were immediately 
frozen and kept at -80ºC and then homogenized at 
the appropriate time.
The  formaldehyde-fixed  samples  were  further 
processed  and  stained  with  hematoxylin  and 
Eosin  and  then  were  examined  microscopically 
by a pathologist to assess the distance between the 
cementoenamel  junction  and  the  alveolar  crest, 
the distance between the cementoenamel junction 
(CEJ) and the most coronal portion of the junctional 
epithelium (JE),  and  the  polymorphonuclear 
leukocytes (PMN) in the connective tissue adjacent 
the JE. 
The  concentration  of  IL-1β,8-hydroxydeoxy-
guanosine (8-OHdG; measure of DNA damage), and 
cellular  lipid  peroxidation (LPO)  were  measured 
according to manufacturer’s instruction. 
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osteoclast  activity  significantly.  Degree  of  apical 
migration of JE in Angipars group was significantly 
lower than that of periodontitis group. 
The increase of gingival PMN by Angipars may be 
explained  by  its  angiogenesis  properties  that  have 
been  reported  previously (18).  In  fact,  PMN  seem 
acting more effectively than lymphocytes in protecting 
microvasculature of periodontitis (19). On the other 
hand,  vehicle  group (ethanol)  increased  PMNs  as 
much  as Angipars.  Of  course,  there  are  conflicting 
data  about  angiogenic  effects  of  ethanol  that  limit 
us to conclude absolutely. Some studies have shown 
suppressive effect of ethanol extract of some plants 
on angiogenesis, whereas others have found inductive 
properties of ethanol extract of different plants (20, 21). 
Thus, angiogenic activity of ethanol in periodontitis 
remains to be elucidated by further studies.
Taking  collectively,  present  findings  are  adequate  to 
conclude that benefit of Angipars in periodontitis comes 
from its anti-oxidative properties. This conclusion is 
supported by a recent clinical trial on diabetic patients 
which showed beneficial effect of Angipars on oxidative 
DNA damage after administration for 3 months (10). 
Unexpected increase of PMNs by Angipars limits our 
conclusion but strengthens the hypothesis that chronic 
inflammatory disorders like periodontitis may requires 
more time to get best advantage of anti oxidative drugs 
like Angipars (22). Also regarding role of microbes 
in  pathogenesis  of  periodontitis,  further  studies  on 
antimicrobial effects of Angipars are required. 
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